Amjad Belramman

Dr. Amjad Belramman is an Honorary Clinical Research Fellow at the Department of Surgery & Cancer within the Faculty of Medicine at Imperial College London. His research focuses on vascular surgery, particularly varicose vein treatments and clinical trial methodologies. He has contributed to randomized controlled trials comparing mechanochemical ablation and cyanoacrylate adhesive techniques, as well as studies on post-procedure compression therapy and foam sclerotherapy efficacy.

Belramman’s work also extends to surgical education, investigating the impact of 2D/3D/4K vision systems and training methods on laparoscopic skill acquisition in novices. His studies include the MOCCA and COMETA trials, evaluating pain outcomes and compression efficacy in endovenous treatments. He has authored protocols for trials comparing foam sclerotherapy and ambulatory phlebectomy.

His research themes emphasize evidence-based practices in chronic venous disease management, including systematic reviews of clinical guidelines. He has no listed awards but maintains active involvement in translational research bridging surgical innovation and patient outcomes.

Belramman’s affiliations include Charing Cross Hospital in London, where he conducts clinical research and contributes to the development of minimally invasive vascular procedures. His work highlights a dual focus on advancing surgical techniques and improving patient-centered care through rigorous trial designs.